The controversial protein-only hypothesis of prion propagation

Nature Medicine

Volumn 10, Issue 7, 2004, Pages S63-

  Soto, Claudio ^a   Castilla, Joaquin ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID;

ARTICLE; EVIDENCE BASED MEDICINE; HUMAN; HYPOTHESIS; IN VITRO STUDY; NEUROPATHOLOGY; NONHUMAN; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN FOLDING; REVIEW; YEAST;

ANIMALS; DISEASE MODELS, ANIMAL; FUNGAL PROTEINS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MODELS, MOLECULAR; PRION DISEASES; PRIONS;

ANIMALIA;

EID: 3142547067     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1069     Document Type: Article

References (55)

1. Collinge, J. Prion diseases of humans and animals: Their causes and molecular basis. Annu. Rev. Neurosci. 24, 519-550 (2001).
2. Prusiner, S.B. Prions. Proc. Natl. Acad. Sci. USA 95, 13363-13383 (1998).
3. Will, R.G. et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347, 921-925 (1996).
4. Collinge, J. Variant Creutzfeldt-Jakob disease. Lancet354, 317-323 (1999).
5. Cullie, J. & Chelle, P.L. Experimental transmission of trembling to the goat. C. R. Seances Acad. Sci. 208, 1058-1160 (1939).
6. Chandler, R.L. Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet 1, 1378-1379 (1961).
7. Gajdusek, D.C., Gibbs, C.J. & Alpers, M. Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature 209, 794-796 (1966).
8. Gibbs, C.J. Jr et al. Creutzfeldt-Jakob disease (spongiform encephalopathy): Transmission to the chimpanzee. Science 161, 388-389 (1968).
9. Masters, C.L., Gajdusek, D.C. & Gibbs, C.J., Jr. Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Straussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain 104, 559-588 (1981).
10. Cho, H.J. Is the scrapie agent a virus? Nature 262, 411-412 (1976).
11. Alper, T., Cramp, W.A., Haig, D.A. & Clarke, M.C. Does the agent of scrapie replicate without nucleic acid? Nature214, 764-766 (1967).
12. Alper, T., Haig, D.A. & Clarke, M.C. The exceptionally small size of the scrapie agent. Biochem. Biophys. Res. Commun. 22, 278-284 (1966).
13. Kimberlin, R.H. Scrapie agent: Prions or virinos? Nature 297, 107-108 (1982).
14. Griffith, J.S. Self-replication and scrapie. Nature 215, 1043-1044 (1967).
15. Prusiner, S.B. Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144 (1982).
16. Bolton, D.C., McKinley, M.P. & Prusiner, S.B. Identification of a protein that purifies with the scrapie prion. Science 218, 1309-1311 (1982).
17. Gabizon, R., McKinley, M.P., Groth, D. & Prusiner, S.B. Immunoaffinity purification and neutralization of scrapie prion infectivity. Proc. Natl. Acad. Sci. USA 85, 6617-6621 (1988).
18. Enari, M., Flechsig, E. & Weissmann, C. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl. Acad. Sci. USA 98, 9295-9299 (2001).
19. Peretz, D. et al. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature412, 739-743 (2001).
20. Oesch, B. et al. A cellular gene encodes scrapie PrP 27-30 protein. Cell 40, 735-746 (1985).
21. Chesebro, B. et al. Identification of scrapie prion protein-specific mRNA in scrapie- infected and uninfected brain. Nature 315, 331-333 (1985).
22. Stahl, N. et al. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 32, 1991-2002 (1993).
23. Pan, K.M. et al. Conversion of a-helices into p-sheets features in the formation of scrapie prion poteins. Proc. Natl. Acad. Sci. USA 90, 10962-10966 (1993).
24. Hsiao, K.K. et al. Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250, 1587-1590 (1990).
25. Hsiao, K.K. et al. Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc. Natl. Acad. Sci. USA 91, 9126-9130 (1994).
26. Barron, R.M. & Manson, J.C. A gene-targeted mouse model of P102L Gerstmann- Straussler-Scheinker syndrome. Clin. Lab. Med. 23, 161-173 (2003).
27. Bueler, H. et al. Mice devoid of PrP are resistant to Scrapie. Cell 73, 1339-1347 (1993).
28. Rubenstein, R., Carp, R.I. & Callahan, S.M. In vitro replication of scrapie agent in a neuronal model: Infection of PC12 cells. J. Gen. Virol. 65, 2191-2198 (1984).
29. Race, R.E., Fadness, L.H. & Chesebro, B. Characterization of scrapie infection in mouse neuroblastoma cells. J. Gen. Virol. 68, 1391-1399 (1987).
30. Kocisko, D.A. et al. Cell-free formation of protease-resistant prion protein. Nature 370, 471-474 (1994).
31. Saborio, G.P., Permanne, B. & Soto, C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810-813 (2001).
32. Chesebro, B. BSE and prions: Uncertainties about the agent. Science 279, 42-43 (1998).
33. Safar, J. et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat. Med. 4, 1157-1165 (1998).
34. Caughey, B., Raymond, G.J. & Bessen, R.A. Strain-dependent differences in p- sheet conformations of abnormal prion protein. J. Biol. Chem. 273, 32230-32235 (1998).
35. Bessen, R.A. et al. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 375, 698-700 (1995).
36. Lasmezas, C.I. et al. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science275, 402-405 (1997).
37. Hill, A.F. et al. Species-barrier-independent prion replication in apparently resistant species. Proc. Natl. Acad. Sci. USA 97, 10248-10253 (2000).
38. Narang, H. A critical review of the nature of the spongiform encephalopathy agent: Protein theory versus virus theory. Exp. Biol. Med. 227, 4-19 (2002).
39. Weiss, S. et al. RNA aptamers specifically interact with the prion protein PrP. J. Virol. 71, 8790-8797 (1997).
40. Derrington, E. et al. PrPC has nucleic acid chaperoning properties similar to the nucleocapsid protein of HIV-1. C. R. Acad. Sci. III 325, 17-23 (2002).
41. Deleault, N.R., Lucassen, R.W. & Supattapone, S. RNA molecules stimulate prion protein conversion. Nature 425, 717-720 (2003).
42. Soto, C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 4, 49-60 (2003).
43. Kane, M.D. et al. Evidence for seeding of p-amyloid by intracerebral infusion of Alzheimer brain extracts in p-amyloid precursor protein-transgenic mice. J. Neurosci. 20, 3606-3611 (2000).
44. Lundmark, K. et al. Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc. Natl. Acad. Sci. USA 99, 6979-6984 (2002).
45. Lehmann, S. & Harris, D.A. Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform. Proc. Natl. Acad. Sci. USA 93, 5610-5614 (1996).
46. Chiesa, R., Piccardo, P., Ghetti, B. & Harris, D.A. Neurological illness in trans- genic mice expressing a prion protein with an insertional mutation. Neuron 21, 1339-1351 (1998).
47. Jackson, G.S. et al. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science 283, 1935-1937 (1999).
48. Hill, A.F., Antoniou, M. & Collinge, J. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J. Gen. Virol. 80, 11-14 (1999).
49. Barret, A. et al. Evaluation of quinacrine treatment for prion diseases. J. Virol. 77, 8462-8469 (2003).
50. Wickner, R.B. [URE3] as an altered URE2 protein: Evidence for a prion analog in Saccharomyces cerevisiae. Science 264, 566-569 (1994).
51. Uptain, S.M. & Lindquist, S. Prions as protein-based genetic elements. Annu. Rev. Microbiol. 56, 703-741 (2002).
52. Sparrer, H.E., Santoso, A., Szoka, F.C., Jr & Weissman, J.S. Evidence for the prion hypothesis: Induction of the yeast [PSI+] factor by in vitro-converted Sup35 protein. Science 289, 595-599 (2000).
53. Maddelein, M.L., Dos, R.S., Duvezin-Caubet, S., Coulary-Salin, B. & Saupe, S.J. Amyloid aggregates of the HET-s prion protein are infectious. Proc. Natl. Acad. Sci. USA 99, 7402-7407 (2002).
54. King, C.Y. & Diaz-Avalos, R. Protein-only transmission of three yeast prion strains. Nature 428, 319-323 (2004).
55. Tanaka, M., Chien, P., Naber, N., Cooke, R. & Weissman, J.S. Conformational variations in an infectious protein determine prion strain differences. Nature 428, 323-328 (2004).